单位：[1]Graduate School, Beijing University of Chinese Medicine, Beijing, China[2]Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China[3]Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China
第一作者单位：[1]Graduate School, Beijing University of Chinese Medicine, Beijing, China[2]Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China
通讯作者：
通讯机构：[3]Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China[*1]Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, No. 2 Yinghua East Street, Beijing 100029, China
推荐引用方式(GB/T 7714)：
Liu Shufang,Niu Wenquan.Different Biomarker Modalities and Response to Anti-PD-1/PD-L1 Therapies[J].JAMA ONCOLOGY.2020,6(2):298-299.doi:10.1001/jamaoncol.2019.5148.
APA：
Liu, Shufang&Niu, Wenquan.(2020).Different Biomarker Modalities and Response to Anti-PD-1/PD-L1 Therapies.JAMA ONCOLOGY,6,(2)
MLA：
Liu, Shufang,et al."Different Biomarker Modalities and Response to Anti-PD-1/PD-L1 Therapies".JAMA ONCOLOGY 6..2(2020):298-299
医学